Cell-based Assay Market was valued at $3,625 million in 2016, and is expected to reach $10,618 million in 2023, registering a CAGR of 16.5% from 2017 to 2023.
Portland, OR -- (SBWIRE) -- 01/11/2018 -- Cell-based Assay Market Overview:
Cell-based Assay Market was valued at $3,625 million in 2016, and is expected to reach $10,618 million in 2023, registering a CAGR of 16.5% from 2017 to 2023. Cell-based assays encompass a variety of assays that measure cellular parameters such as cell toxicity, proliferation, production of markers, activation of specific signaling pathways, motility, and changes in morphology.
These assays rely on reporter gene assays, which have high sensitivity owing to signal amplification of cell-signaling cascades, and thus are ideal for miniaturization. Cell-based assays are widely applied in high-throughput screening (HTS) formats.
The demand for cell-based assay has increased significantly over the past few years, owing to surge in cell-based applications in drug discovery and rise in technological advancements in cell-based assays methodologies. In addition, adoption of high-throughput screening methods and increase in R&D investment further drive the market growth. However, high costs associated with these assays and lack of skilled professionals hamper this growth. Furthermore, surge in adoption of label-free cell-based assays and untapped potential in developing countries offer significant opportunities to the market players.
Save Upto 15% on this Report @ https://www.researchbeam.com/cell-based-assay-market/purchase-enquiry
Global Cell-based Assay Market Segmentation
The cell-based assay market is segmented based on product, application, end user, and geography. Based on product, it is categorized into consumable, instrument, service, and software. The consumable segment includes reagents, microplates, probes & labels, assay kits, cell lines, and others.
Assay kits are further sub-divided into reporter gene assays, cell growth assays, second messenger assays, cell death assays, and others. Likewise, the cell lines are divided into immortalized cell lines, primary cell lines, and stem cell lines. Based on application, the market is divided into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others.
On the basis of end user, it is categorized into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Cell-based Assay Market, by Geography, 2016-2023 ($MILLION)
North America generated the highest revenue in the global cell-based assay market in 2016. However, Asia-Pacific possesses market potential for growth of cell-based assays, owing to increase in awareness about these assays for drug discovery, rise in cell-based assay applications, and others. This region is anticipated to experience fast-paced growth, in terms of development and use of cell-based assays.
The consumables hold a significant share in the global cell-based assay market. This trend is expected to continue during the forecast period.
Get the sample PDF Brochure of market study @ https://www.researchbeam.com/cell-based-assay-market/request-sample
Global Cell-based Assay Market, by Product 2016 (%)
The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation
The other prominent players in the value chain include Macrogen, Inc., New England Biolabs, Inc., Cisbio Bioassays, Cell Biolabs, Inc., and DiscoverX Corporation
The study provides an in-depth analysis of the global cell-based assay market, with current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.
Cell-based Assay Market Key Segments:
Probes & Labels
Reporter Gene Assays
Cell Growth Assays
Second Messenger Assays
Cell Death Assays
Immortalized Cell Lines
Primary Cell Lines
Stem Cell Lines
By End User
Pharmaceutical & Biotechnology Companies
Academic & Government Research Institutes
Contract Research Organizations
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA